Results 1 to 10 of about 3,898 (123)

The Comparison of the Mortality Rates of Plasmapheresis/Hemoperfusion Therapy With Current Treatment Among Covid-19 Patients

Heliyon, 2022
Background: There is no definitive treatment for COVID-19. Hemoperfusion and plasmapheresis have only been studied in a few cases of COVID-19. In this study, plasmapheresis-hemoperfusion and current treatment for COVID-19 patients were compared for ...
Maryam Haddadzadeh, Mehrdad Dargahi
exaly   +3 more sources

Research Progress on Blood Compatibility of Hemoperfusion Adsorbent Materials

Frontiers in Bioengineering and Biotechnology
This comprehensive review examines the latest developments in improving the blood compatibility of hemoperfusion adsorbents. By leveraging advanced coating and modification techniques, including albumin-collodion, cellulose, hydrogel, and heparin ...
Liangqing Zhang, Qingping Xia, Guohao Liu   +2 more
exaly   +3 more sources

Initial Experience of Using Polymyxin B Hemoperfusion in Abdominal Septic Shock: Things to Consider for Better Outcome [PDF]

Journal of Acute Care Surgery, 2020
Purpose Polymyxin B hemoperfusion (which treats septic shock by removing endotoxins of gram-negative bacteria), has been proposed as a treatment modality for intraabdominal sepsis.
Young Jun Park, Eun Young Kim
doaj   +1 more source

Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility [PDF]

Kidney Research and Clinical Practice, 2023
Hemoperfusion has been considered a promising adjuvant treatment for chronic diseases and some acute states when specific removal of pathogenic factors from the bloodstream is desired. Over the years, advances in adsorption materials (e.g., new synthetic
Aikaterini Damianaki, Emelina Stambolliu, Zoi Alexakou, Dimitrios Petras   +3 more
doaj   +1 more source

Evaluation of the Role of Hemoperfusion on Mortality and Morbidity in Patients with Severe Coronavirus Disease 2019 (COVID- 19)

Archives of Anesthesia and Critical Care, 2023
Background: Cytokine storm in severe Covid-19 disease is one of the leading causes of death in these patients. Hemoperfusion is a method used to purify the blood from toxins and inflammatory factors.
Atabak Najafi, Arezoo Ahmadi, Mojtaba Mojtahed-Zadeh, Nasim Zarrin, Reza Shariat Moharrari, Mohammad Reza Khajavi, Farhad Etezadi, Pejman Pourfakhr, Mohammad Reza Neishaboury   +8 more
doaj   +1 more source

The effect of hemoperfusion on the outcome, clinical and laboratory findings of patients with severe COVID-19: a retrospective study

New Microbes and New Infections, 2021
Hemoperfusion is a method of blood filtering to remove toxins and inflammatory factors. Cytokine storms and high levels of inflammatory factors play a role in the pathogenesis of coronavirus disease 2019 (COVID-19). The present study aims to evaluate the
A. Soleimani, S.M. Moeini Taba, S. Hasibi Taheri, A.H. Loghman, M. Shayestehpour   +4 more
doaj   +1 more source

Hemoperfusion: technical aspects and state of the art

Critical Care, 2022
Background Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history.
Claudio Ronco, Rinaldo Bellomo
doaj   +1 more source

Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?

Journal of Research in Medical Sciences, 2021
Background: The new coronavirus outbreak quickly filled hospital beds and stunned the world. Intensive care is required for 5% of patients, and the mortality rate for critically ill patients is 49%. The “cytokine storm” is considered as the main cause of
Saeed Abbasi, Zohre Naderi, Babak Amra, Abdolamir Atapour, Seyed Amir Dadkhahi, Mohammad Javad Eslami, Mohammad Reza Hajian, Marzieh Hashemi, Seyed Taghi Hashemi, Bijan Iraj, Farzin Khorvash, Samane Madadi, Hossein Mahjoubi Pour, Marjan Mansourian, Majid Rezvani, Ramin Sami, Forough Soltaninejad, Shahrzad Shahidi, Sahar Vahdat, Zahra Zamani, Firouzeh Moeinzadeh   +20 more
doaj   +1 more source

Comparison of the Effects of Continuous Renal Replacement Therapy and Hemodialysis on Complications, Vital Signs, and Laboratory Parameters in Patients with COVID-19

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Evidence shows that continuous renal replacement therapy (CRRT) and hemodialysis may be effective in the treatment of Coronavirus disease-2019 (COVID-19).
Shahrzad IZADI, Mohammad MEMARIAN, Zahra Shaabani KHATIB, Samaneh LAVAF, Kamyar MANSORI   +4 more
doaj   +1 more source

Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study. [PDF]

PLoS ONE, 2014
Paraquat poisoning associates very high mortality rate. Early treatment with hemoperfusion is strongly suggested by animal and human studies. Although the survival benefit of additional immunosuppressive treatment (IST) in combination with hemoperfusion ...
Wen-Pyng Wu, Ming-Nan Lai, Ching-Heng Lin, Yu-Fen Li, Ching-Yuang Lin, Ming-Ju Wu   +5 more
doaj   +1 more source